{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T06:19:13Z","timestamp":1706077153424},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/maj.0b013e3181c6440e","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T08:10:43Z","timestamp":1269418243000},"page":"549-556","source":"Crossref","is-referenced-by-count":7,"title":["Viruses and Arthritis: New Challenges in Diagnosis, Therapy, and Immunization"],"prefix":"10.1016","volume":"339","author":[{"given":"Andreas","family":"Reimold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biff F.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0015","series-title":"Specific viruses that cause arthritis","author":"Moore","year":"2009"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.20502","article-title":"Elevated prevalence of hepatitis C infection in users of United States veterans medical centers","volume":"41","author":"Dominitz","year":"2005","journal-title":"Hepatology"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1537-2995.2000.40080917.x","article-title":"Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study","volume":"40","author":"Tobler","year":"2000","journal-title":"Transfusion"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0030","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0035","first-page":"447","article-title":"Extrahepatic manifestations in patients with chronic hepatitis C virus infection","volume":"17","author":"Ramos-Casals","year":"2005","journal-title":"Curr Opin Rheum"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0040","first-page":"378","article-title":"The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C","volume":"1","author":"Jia","year":"2002","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0198-8859(03)00080-6","article-title":"IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection","volume":"64","author":"Lio","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00011-006-0082-0","article-title":"Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury","volume":"55","author":"Riordan","year":"2006","journal-title":"Inflamm Res"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0055","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1572-0241.2003.08728.x","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association","volume":"98","author":"Knobler","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/14656566.6.1.27","article-title":"Management of hepatitis C virus-related arthritis","volume":"6","author":"Palazzi","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3816\/CLM.2006.n.052","article-title":"Response to rituximab in patients with type II cryoglobulinemia","volume":"7","author":"Bryce","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1601-0825.2007.01436.x","article-title":"Oral diseases associated with hepatitis C virus infection. Part 1. Sialadenitis and salivary glands lymphoma","volume":"14","author":"Carrozzo","year":"2008","journal-title":"Oral Dis"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Int Med"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0085","first-page":"2390","article-title":"Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis","volume":"33","author":"Matsui","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0090","first-page":"S631","article-title":"Use of anti-cyclic citrullinated peptide antibodies to distinguish between rheumatoid arthritis and hepatitis C virus infection associated polyarthritis","volume":"54","author":"Abdel Baky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0095","first-page":"57","article-title":"Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis","volume":"22","author":"Riccio","year":"2008","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3899\/jrheum.081308","article-title":"Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study","volume":"36","author":"Guennoc","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2004.11.025","article-title":"Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study","volume":"42","author":"Zein","year":"2005","journal-title":"J Hepatol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0110","first-page":"821A","article-title":"Effect of infliximab on the efficacy of peginterferon alfa-2B (PEG-2B) plus ribavirin (RBV) therapy in treatment-na\u00efve patients with hepatitis C genotype 1 and high tumor necrosis factor a (TNF-a) levels","volume":"46","author":"Cooper","year":"2007","journal-title":"Hepatology"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1196\/annals.1361.100","article-title":"Autoimmunity and anti-TNF-alpha agents","volume":"1051","author":"Atzeni","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0120","first-page":"290","article-title":"Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalities","volume":"17","author":"Vauloup","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0125","first-page":"421","article-title":"Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis","volume":"35","author":"Cansu","year":"2008","journal-title":"J Rheum"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0135","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn\u2019s disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0140","first-page":"S554","article-title":"Possible reactivation of past hbv infection by the anti-TNF-\u03b1 blocker for the treatment of rheumatic diseases","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0145","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","article-title":"Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks","volume":"180","author":"Anolik","year":"2008","journal-title":"J Immunol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.medmal.2009.01.009","article-title":"Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease","volume":"39","author":"Lanternier","year":"2009","journal-title":"Med Mal Infect"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0155","series-title":"Inactivated influenza vaccine: what you need to know 2008-2009","year":"2008"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0160","first-page":"1469","article-title":"Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus?","volume":"33","author":"Mercado","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/BOR.0b013e3282ffdeca","article-title":"Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate","volume":"20","author":"Brezinschek","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0175","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/s10165-008-0135-z","article-title":"Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers","volume":"19","author":"Nii","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0180","series-title":"Herpes zoster (shingles) vaccine guidelines for immunosuppressed patients","author":"Cush","year":"2008"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0185","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/kel328","article-title":"Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders","volume":"45","author":"Wolfe","year":"2006","journal-title":"Rheumatology"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0190","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0195","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/598331","article-title":"Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis","volume":"48","author":"McDonald","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0200","series-title":"Zostavax","year":"2009"},{"key":"10.1097\/MAJ.0b013e3181c6440e_bb0205","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP); Centers for Disease Control and Prevention (CDC). Prevention ofherpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915315792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915315792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T03:59:57Z","timestamp":1635134397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915315792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0002962915315792"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3181c6440e","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}